Compounds > rivaroxaban

rivaroxaban and Splenic-Rupture

rivaroxaban has been researched along with Splenic-Rupture* in 3 studies

Other Studies

3 other study(ies) available for rivaroxaban and Splenic-Rupture

ArticleYear
Spontaneous splenic rupture due to rivaroxaban.
    BMJ case reports, 2018, Mar-05, Volume: 2018

    In the prevention and treatment of thromboembolic disease, novel oral anticoagulants have emerged as alternatives to warfarin. A major challenge continues to be the reversal of their anticoagulant effect in the case of life-threatening haemorrhagic complications. We report a case of spontaneous splenic rupture treated by splenic artery embolisation in a 77-year-old woman who was anticoagulated with rivaroxaban.

    Topics: Aged; Atrial Fibrillation; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Rivaroxaban; Rupture, Spontaneous; Splenic Artery; Splenic Rupture

2018
Spontaneous splenic rupture due to rivaroxaban.
    Drug and therapeutics bulletin, 2018, Volume: 56, Issue:11

    In conjunction with

    Topics: Aged; Factor Xa Inhibitors; Female; Humans; Rivaroxaban; Splenic Rupture; Thromboembolism

2018
Hemorrhagic Shock from Spontaneous Splenic Rupture Requiring Open Splenectomy in a Patient Taking Rivaroxaban.
    The American surgeon, 2016, Volume: 82, Issue:2

    Topics: Aged; Factor Xa Inhibitors; Female; Humans; Rivaroxaban; Rupture, Spontaneous; Shock, Hemorrhagic; Splenectomy; Splenic Rupture

2016